{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:32:59Z","timestamp":1793975579055,"version":"4.8.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-50770-7","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T06:04:16Z","timestamp":1724393056000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["A broadly cross-reactive i-body to AMA1 potently inhibits blood and liver stages of Plasmodium parasites"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4776-487X","authenticated-orcid":false,"given":"Dimuthu","family":"Angage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Chmielewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janesha C.","family":"Maddumage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Hesping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Caiazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2111-0466","authenticated-orcid":false,"given":"Keng Heng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7872-762X","authenticated-orcid":false,"given":"Lee Ming","family":"Yeoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Menassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4589-4365","authenticated-orcid":false,"given":"D. Herbert","family":"Opi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Callum","family":"Cairns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5178-1175","authenticated-orcid":false,"given":"Hamsa","family":"Puthalakath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1018-7898","authenticated-orcid":false,"given":"James G.","family":"Beeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2639-2498","authenticated-orcid":false,"given":"Marc","family":"Kvansakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7322-2040","authenticated-orcid":false,"given":"Justin A.","family":"Boddey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5073-1405","authenticated-orcid":false,"given":"Danny W.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin F.","family":"Anders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1349-4698","authenticated-orcid":false,"given":"Michael","family":"Foley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,22]]},"reference":[{"key":"50770_CR1","unstructured":"World Health Organization. World Malaria Report 2022 (WHO, 2022)."},{"key":"50770_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.50","volume":"3","author":"MA Phillips","year":"2017","unstructured":"Phillips, M. A. et al. Malaria. Nat. Rev. Dis. Prim. 3, 17050 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"50770_CR3","doi-asserted-by":"publisher","first-page":"e1003890","DOI":"10.1371\/journal.pmed.1003890","volume":"19","author":"AP Phyo","year":"2022","unstructured":"Phyo, A. P., Dahal, P., Mayxay, M. & Ashley, E. A. Clinical impact of vivax malaria: a collection review. PLoS Med. 19, e1003890 (2022).","journal-title":"PLoS Med."},{"key":"50770_CR4","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nm.3073","volume":"19","author":"LH Miller","year":"2013","unstructured":"Miller, L. H., Ackerman, H. C., Su, X.-Z. & Wellems, T. E. Malaria biology and disease pathogenesis: insights for new treatments. Nat. Med. 19, 156\u2013167 (2013).","journal-title":"Nat. Med."},{"key":"50770_CR5","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.ijpara.2004.10.010","volume":"34","author":"D Gaur","year":"2004","unstructured":"Gaur, D., Mayer, D. C. G. & Miller, L. H. Parasite ligand\u2013host receptor interactions during invasion of erythrocytes by Plasmodium merozoites. Int. J. Parasitol. 34, 1413\u20131429 (2004).","journal-title":"Int. J. Parasitol."},{"key":"50770_CR6","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1371\/journal.ppat.0010037","volume":"1","author":"J Baum","year":"2005","unstructured":"Baum, J., Maier, A. G., Good, R. T., Simpson, K. M. & Cowman, A. F. Invasion by P. falciparum merozoites suggests a hierarchy of molecular interactions. PLoS Pathog. 1, e37 (2005).","journal-title":"PLoS Pathog."},{"key":"50770_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1083\/jcb.77.1.72","volume":"77","author":"M Aikawa","year":"1978","unstructured":"Aikawa, M., Miller, L., Johnson, J. & Rabbege, J. Erythrocyte entry by malarial parasites. A moving junction between erythrocyte and parasite. J. Cell Biol. 77, 72\u201382 (1978).","journal-title":"J. Cell Biol."},{"key":"50770_CR8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3389\/fimmu.2014.00359","volume":"5","author":"AE Barry","year":"2014","unstructured":"Barry, A. E. & Arnott, A. Strategies for designing and monitoring malaria vaccines targeting diverse antigens. Front. Immunol. 5, 359 (2014).","journal-title":"Front. Immunol."},{"key":"50770_CR9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3389\/fimmu.2020.00335","volume":"11","author":"CJ Mitran","year":"2020","unstructured":"Mitran, C. J. & Yanow, S. K. The case for exploiting cross-species epitopes in malaria vaccine design. Front. Immunol. 11, 335 (2020).","journal-title":"Front. Immunol."},{"key":"50770_CR10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/femsre\/fuz005","volume":"43","author":"AL Burns","year":"2019","unstructured":"Burns, A. L. et al. Targeting malaria parasite invasion of red blood cells as an antimalarial strategy. FEMS Microbiol. Rev. 43, 223\u2013238 (2019).","journal-title":"FEMS Microbiol. Rev."},{"key":"50770_CR11","doi-asserted-by":"publisher","first-page":"e1000309","DOI":"10.1371\/journal.ppat.1000309","volume":"5","author":"S Besteiro","year":"2009","unstructured":"Besteiro, S., Michelin, A., Poncet, J., Dubremetz, J.-F. & Lebrun, M. Export of a Toxoplasma gondii rhoptry neck protein complex at the host cell membrane to form the moving junction during invasion. PLoS Pathog. 5, e1000309 (2009).","journal-title":"PLoS Pathog."},{"key":"50770_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.chom.2010.12.003","volume":"9","author":"DT Riglar","year":"2011","unstructured":"Riglar, D. T. et al. Super-resolution dissection of coordinated events during malaria parasite invasion of the human erythrocyte. Cell Host Microbe 9, 9\u201320 (2011).","journal-title":"Cell Host Microbe"},{"key":"50770_CR13","doi-asserted-by":"publisher","first-page":"13275","DOI":"10.1073\/pnas.1110303108","volume":"108","author":"P Srinivasan","year":"2011","unstructured":"Srinivasan, P. et al. Binding of Plasmodium merozoite proteins RON2 and AMA1 triggers commitment to invasion. Proc. Natl Acad. Sci. USA 108, 13275\u201313280 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"50770_CR14","doi-asserted-by":"publisher","first-page":"e12745","DOI":"10.1111\/cmi.12745","volume":"19","author":"ASP Yang","year":"2017","unstructured":"Yang, A. S. P. et al. AMA1 and MAEBL are important for Plasmodium falciparum sporozoite infection of the liver. Cell. Microbiol. 19, e12745 (2017).","journal-title":"Cell. Microbiol."},{"key":"50770_CR15","doi-asserted-by":"publisher","first-page":"e1010643","DOI":"10.1371\/journal.ppat.1010643","volume":"18","author":"P Fernandes","year":"2022","unstructured":"Fernandes, P. et al. The AMA1-RON complex drives Plasmodium sporozoite invasion in the mosquito and mammalian hosts. PLoS Pathog. 18, e1010643 (2022).","journal-title":"PLoS Pathog."},{"key":"50770_CR16","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/mmi.14645","volume":"115","author":"M Loubens","year":"2021","unstructured":"Loubens, M. et al. Plasmodium sporozoites on the move: switching from cell traversal to productive invasion of hepatocytes. Mol. Microbiol. 115, 870\u2013881 (2021).","journal-title":"Mol. Microbiol."},{"key":"50770_CR17","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/infdis\/jix583","volume":"217","author":"DR Drew","year":"2017","unstructured":"Drew, D. R. et al. Functional conservation of the AMA1 host-cell invasion ligand between P. falciparum and P. vivax: a novel platform to accelerate vaccine and drug development. J. Infect. Dis. 217, 498\u2013507 (2017).","journal-title":"J. Infect. Dis."},{"key":"50770_CR18","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/femsre\/fuw001","volume":"40","author":"JG Beeson","year":"2016","unstructured":"Beeson, J. G. et al. Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria. FEMS Microbiol. Rev. 40, 343\u2013372 (2016).","journal-title":"FEMS Microbiol. Rev."},{"key":"50770_CR19","doi-asserted-by":"publisher","first-page":"6948","DOI":"10.1128\/IAI.70.12.6948-6960.2002","volume":"70","author":"MC Kennedy","year":"2002","unstructured":"Kennedy, M. C. et al. In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response. Infect. Immun. 70, 6948\u20136960 (2002).","journal-title":"Infect. Immun."},{"key":"50770_CR20","doi-asserted-by":"publisher","first-page":"12736","DOI":"10.1073\/pnas.0501808102","volume":"102","author":"T Bai","year":"2005","unstructured":"Bai, T. et al. Structure of AMA1 from Plasmodium falciparum reveals a clustering of polymorphisms that surround a conserved hydrophobic pocket. Proc. Natl Acad. Sci. USA 102, 12736\u201312741 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"50770_CR21","first-page":"1308","volume":"3","author":"AM Coley","year":"2007","unstructured":"Coley, A. M. et al. Structure of the malaria antigen AMA1 in complex with a growth-inhibitory antibody. PLoS Pathog. 3, 1308\u20131319 (2007).","journal-title":"PLoS Pathog."},{"key":"50770_CR22","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1128\/IAI.69.5.3286-3294.2001","volume":"69","author":"AN Hodder","year":"2001","unstructured":"Hodder, A. N., Crewther, P. E. & Anders, R. F. Specificity of the protective antibody response to apical membrane antigen 1. Infect. Immun. 69, 3286\u20133294 (2001).","journal-title":"Infect. Immun."},{"key":"50770_CR23","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1056\/NEJMoa1008115","volume":"365","author":"MA Thera","year":"2011","unstructured":"Thera, M. A. et al. A field trial to assess a blood-stage malaria vaccine. N. Engl. J. Med. 365, 1004\u20131013 (2011).","journal-title":"N. Engl. J. Med."},{"key":"50770_CR24","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1128\/IAI.00170-08","volume":"76","author":"EJ Remarque","year":"2008","unstructured":"Remarque, E. J., Faber, B. W., Kocken, C. H. M. & Thomas, A. W. A diversity-covering approach to immunization with Plasmodium falciparum apical membrane antigen 1 induces broader allelic recognition and growth inhibition responses in rabbits. Infect. Immun. 76, 2660\u20132670 (2008).","journal-title":"Infect. Immun."},{"key":"50770_CR25","doi-asserted-by":"publisher","first-page":"e1003840","DOI":"10.1371\/journal.ppat.1003840","volume":"9","author":"S Dutta","year":"2013","unstructured":"Dutta, S. et al. Overcoming antigenic diversity by enhancing the immunogenicity of conserved epitopes on the malaria vaccine candidate apical membrane antigen-1. PLoS Pathog. 9, e1003840 (2013).","journal-title":"PLoS Pathog."},{"key":"50770_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-10-182","volume":"10","author":"KA Kusi","year":"2011","unstructured":"Kusi, K. A. et al. Safety and immunogenicity of multi-antigen AMA1-based vaccines formulated with CoVaccine HT\u2122 and Montanide ISA 51 in rhesus macaques. Malar. J. 10, 182 (2011).","journal-title":"Malar. J."},{"key":"50770_CR27","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.jmb.2006.12.028","volume":"366","author":"S Igonet","year":"2007","unstructured":"Igonet, S. et al. Cross-reactivity studies of an anti-Plasmodium vivax apical membrane antigen 1 monoclonal antibody: binding and structural characterisation. J. Mol. Biol. 366, 1523\u20131537 (2007).","journal-title":"J. Mol. Biol."},{"key":"50770_CR28","doi-asserted-by":"publisher","first-page":"e1000273","DOI":"10.1371\/journal.ppat.1000273","volume":"5","author":"CR Collins","year":"2009","unstructured":"Collins, C. R., Withers-Martinez, C., Hackett, F. & Blackman, M. J. An inhibitory antibody blocks interactions between components of the malarial invasion machinery. PLoS Pathog. 5, e1000273 (2009).","journal-title":"PLoS Pathog."},{"key":"50770_CR29","doi-asserted-by":"publisher","first-page":"12641","DOI":"10.1074\/jbc.M116.721050","volume":"291","author":"K Griffiths","year":"2016","unstructured":"Griffiths, K. et al. i-bodies, human single domain antibodies that antagonize chemokine receptor CXCR4. J. Biol. Chem. 291, 12641\u201312657 (2016).","journal-title":"J. Biol. Chem."},{"key":"50770_CR30","doi-asserted-by":"publisher","first-page":"12444","DOI":"10.1073\/pnas.0403509101","volume":"101","author":"VA Streltsov","year":"2004","unstructured":"Streltsov, V. A. et al. Structural evidence for evolution of shark Ig new antigen receptor variable domain antibodies from a cell-surface receptor. Proc. Natl Acad. Sci. USA 101, 12444\u201312449 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"50770_CR31","doi-asserted-by":"publisher","first-page":"e143018","DOI":"10.1172\/jci.insight.143018","volume":"7","author":"Q Cao","year":"2022","unstructured":"Cao, Q. et al. A single-domain i-body, AD-114, attenuates renal fibrosis through blockade of CXCR4. JCI Insight 7, e143018 (2022).","journal-title":"JCI Insight"},{"key":"50770_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.102889","volume":"299","author":"H Qiu","year":"2023","unstructured":"Qiu, H. et al. ADR3, a next generation i-body to human RANKL, inhibits osteoclast formation and bone resorption. J. Biol. Chem. 299, 102889 (2023).","journal-title":"J. Biol. Chem."},{"key":"50770_CR33","doi-asserted-by":"publisher","first-page":"e51023","DOI":"10.1371\/journal.pone.0051023","volume":"7","author":"DR Drew","year":"2012","unstructured":"Drew, D. R. et al. Defining the antigenic diversity of Plasmodium falciparum apical membrane antigen 1 and the requirements for a multi-allele vaccine against malaria. PLoS ONE 7, e51023 (2012).","journal-title":"PLoS ONE"},{"key":"50770_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-014-0183-5","volume":"12","author":"U Terheggen","year":"2014","unstructured":"Terheggen, U. et al. Limited antigenic diversity of Plasmodium falciparum apical membrane antigen 1 supports the development of effective multi-allele vaccines. BMC Med. 12, 183 (2014).","journal-title":"BMC Med."},{"key":"50770_CR35","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1128\/IAI.74.5.2628-2636.2006","volume":"74","author":"AM Coley","year":"2006","unstructured":"Coley, A. M. et al. The most polymorphic residue on Plasmodium falciparum apical membrane antigen 1 determines binding of an invasion-inhibitory antibody. Infect. Immun. 74, 2628\u20132636 (2006).","journal-title":"Infect. Immun."},{"key":"50770_CR36","doi-asserted-by":"publisher","first-page":"e1002755","DOI":"10.1371\/journal.ppat.1002755","volume":"8","author":"B Vulliez-Le Normand","year":"2012","unstructured":"Vulliez-Le Normand, B. et al. Structural and functional insights into the malaria parasite moving junction complex. PLoS Pathog. 8, e1002755 (2012).","journal-title":"PLoS Pathog."},{"key":"50770_CR37","doi-asserted-by":"publisher","first-page":"100","DOI":"10.12703\/P6-100","volume":"6","author":"SR Elliott","year":"2014","unstructured":"Elliott, S. R. et al. Research priorities for the development and implementation of serological tools for malaria surveillance. F1000Prime Rep. 6, 100 (2014).","journal-title":"F1000Prime Rep."},{"key":"50770_CR38","doi-asserted-by":"publisher","first-page":"7310","DOI":"10.1021\/bi5012089","volume":"53","author":"SS Lim","year":"2014","unstructured":"Lim, S. S. et al. Structure and dynamics of apical membrane antigen 1 from Plasmodium falciparum FVO. Biochemistry 53, 7310\u20137320 (2014).","journal-title":"Biochemistry"},{"key":"50770_CR39","doi-asserted-by":"publisher","first-page":"e0183198","DOI":"10.1371\/journal.pone.0183198","volume":"12","author":"B Vulliez-Le Normand","year":"2017","unstructured":"Vulliez-Le Normand, B., Saul, F. A., Hoos, S., Faber, B. W. & Bentley, G. A. Cross-reactivity between apical membrane antgen 1 and rhoptry neck protein 2 in P. vivax and P. falciparum: a structural and binding study. PLoS ONE 12, e0183198 (2017).","journal-title":"PLoS ONE"},{"key":"50770_CR40","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.str.2007.09.011","volume":"15","author":"KA Henderson","year":"2007","unstructured":"Henderson, K. A. et al. Structure of an IgNAR-AMA1 complex: targeting a conserved hydrophobic cleft broadens malarial strain recognition. Structure 15, 1452\u20131466 (2007).","journal-title":"Structure"},{"key":"50770_CR41","doi-asserted-by":"publisher","first-page":"W382","DOI":"10.1093\/nar\/gki387","volume":"33","author":"J Schymkowitz","year":"2005","unstructured":"Schymkowitz, J. et al. The FoldX web server: an online force field. Nucleic Acids Res. 33, W382\u2013W388 (2005).","journal-title":"Nucleic Acids Res."},{"key":"50770_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-020-03548-3","volume":"20","author":"M Seidel-Greven","year":"2021","unstructured":"Seidel-Greven, M. et al. Isolation and light chain shuffling of a Plasmodium falciparum AMA1-specific human monoclonal antibody with growth inhibitory activity. Malar. J. 20, 37 (2021).","journal-title":"Malar. J."},{"key":"50770_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/srep39462","volume":"6","author":"DJ Maskus","year":"2016","unstructured":"Maskus, D. J. et al. Characterization of a novel inhibitory human monoclonal antibody directed against Plasmodium falciparum apical membrane antigen 1. Sci. Rep. 6, 39462 (2016).","journal-title":"Sci. Rep."},{"key":"50770_CR44","doi-asserted-by":"publisher","first-page":"9490","DOI":"10.1074\/jbc.M311331200","volume":"279","author":"O Silvie","year":"2004","unstructured":"Silvie, O. et al. A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites. J. Biol. Chem. 279, 9490\u20139496 (2004).","journal-title":"J. Biol. Chem."},{"key":"50770_CR45","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/00034983.1975.11686997","volume":"69","author":"W Peters","year":"1975","unstructured":"Peters, W. The chemotherapy of rodent malaria, XXII. The value of drug-resistant strains of P. berghei in screening for blood schizontocidal activity. Ann. Trop. Med. Parasitol. 69, 155\u2013171 (1975).","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"50770_CR46","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1128\/iai.64.8.3310-3317.1996","volume":"64","author":"PE Crewther","year":"1996","unstructured":"Crewther, P. E., Matthew, M. L., Flegg, R. H. & Anders, R. F. Protective immune responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of strain-specific epitopes. Infect. Immun. 64, 3310\u20133317 (1996).","journal-title":"Infect. Immun."},{"key":"50770_CR47","doi-asserted-by":"publisher","first-page":"e1045","DOI":"10.1371\/journal.pone.0001045","volume":"2","author":"A Dicko","year":"2007","unstructured":"Dicko, A. et al. Impact of a Plasmodium falciparum AMA1 vaccine on antibody responses in adult Malians. PLoS ONE 2, e1045 (2007).","journal-title":"PLoS ONE"},{"key":"50770_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-9-175","volume":"9","author":"A Ouattara","year":"2010","unstructured":"Ouattara, A. et al. Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine. Malar. J. 9, 175 (2010).","journal-title":"Malar. J."},{"key":"50770_CR49","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1080\/19420862.2018.1489633","volume":"10","author":"KA Henry","year":"2018","unstructured":"Henry, K. A. & MacKenzie, C. R. Antigen recognition by single-domain antibodies: structural latitudes and constraints. mAbs 10, 815\u2013826 (2018).","journal-title":"mAbs"},{"key":"50770_CR50","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s00018-023-04712-z","volume":"80","author":"DR Drew","year":"2023","unstructured":"Drew, D. R. et al. Defining species-specific and conserved interactions of apical membrane protein 1 during erythrocyte invasion in malaria to inform multi-species vaccines. Cell. Mol. Life Sci. 80, 74 (2023).","journal-title":"Cell. Mol. Life Sci."},{"key":"50770_CR51","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1038\/s41564-022-01261-2","volume":"7","author":"SW Scally","year":"2022","unstructured":"Scally, S. W. et al. PCRCR complex is essential for invasion of human erythrocytes by Plasmodium falciparum. Nat. Microbiol. 7, 2039\u20132053 (2022).","journal-title":"Nat. Microbiol."},{"key":"50770_CR52","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S1473-3099(22)00793-9","volume":"23","author":"KE Lyke","year":"2023","unstructured":"Lyke, K. E. et al. Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial. Lancet Infect. Dis. 23, 578\u2013588 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"50770_CR53","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2215003120","volume":"120","author":"S-K Lee","year":"2023","unstructured":"Lee, S.-K. et al. The direct binding of Plasmodium vivax AMA1 to erythrocytes defines a RON2-independent invasion pathway. Proc. Natl Acad. Sci. USA 120, e2215003120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"50770_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-9-77","volume":"9","author":"U Woehlbier","year":"2010","unstructured":"Woehlbier, U., Epp, C., Hackett, F., Blackman, M. J. & Bujard, H. Antibodies against multiple merozoite surface antigens of the human malaria parasite Plasmodium falciparum inhibit parasite maturation and red blood cell invasion. Malar. J. 9, 77 (2010).","journal-title":"Malar. J."},{"key":"50770_CR55","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1080\/19420862.2019.1626652","volume":"11","author":"K Griffiths","year":"2019","unstructured":"Griffiths, K. et al. Half-life extension and non-human primate pharmacokinetic safety studies of i-body AD-114 targeting human CXCR4. mAbs 11, 1331\u20131340 (2019).","journal-title":"mAbs"},{"key":"50770_CR56","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s40259-023-00623-4","volume":"37","author":"DI Stanisic","year":"2023","unstructured":"Stanisic, D. I. & Good, M. F. Malaria vaccines: progress to date. BioDrugs 37, 737\u2013756 (2023).","journal-title":"BioDrugs"},{"key":"50770_CR57","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S0140-6736(23)01456-3","volume":"402","author":"S Devi","year":"2023","unstructured":"Devi, S. 12 countries to get first doses of malaria vaccine. Lancet 402, 172 (2023).","journal-title":"Lancet"},{"key":"50770_CR58","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/S1473-3099(22)00442-X","volume":"22","author":"MS Datoo","year":"2022","unstructured":"Datoo, M. S. et al. Efficacy and immunogenicity of R21\/Matrix-M vaccine against clinical malaria after 2 years\u2019 follow-up in children in Burkina Faso: a phase 1\/2b randomised controlled trial. Lancet Infect. Dis. 22, 1728\u20131736 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"50770_CR59","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(19)30937-7","volume":"393","author":"P Adepoju","year":"2019","unstructured":"Adepoju, P. RTS,S malaria vaccine pilots in three African countries. Lancet 393, 1685 (2019).","journal-title":"Lancet"},{"key":"50770_CR60","doi-asserted-by":"publisher","first-page":"10311","DOI":"10.1073\/pnas.1409928111","volume":"111","author":"P Srinivasan","year":"2014","unstructured":"Srinivasan, P. et al. Immunization with a functional protein complex required for erythrocyte invasion protects against lethal malaria. Proc. Natl Acad. Sci. USA 111, 10311\u201310316 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"50770_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40878-7","volume":"14","author":"PN Patel","year":"2023","unstructured":"Patel, P. N. et al. Structure-based design of a strain transcending AMA1-RON2L malaria vaccine. Nat. Commun. 14, 5345 (2023).","journal-title":"Nat. Commun."},{"key":"50770_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41636-5","volume":"14","author":"S Yanik","year":"2023","unstructured":"Yanik, S. et al. Structure guided mimicry of an essential P. falciparum receptor-ligand complex enhances cross neutralizing antibodies. Nat. Commun. 14, 5879 (2023).","journal-title":"Nat. Commun."},{"key":"50770_CR63","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/nm.4512","volume":"24","author":"NK Kisalu","year":"2018","unstructured":"Kisalu, N. K. et al. A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite. Nat. Med. 24, 408\u2013416 (2018).","journal-title":"Nat. Med."},{"key":"50770_CR64","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1056\/NEJMoa2206966","volume":"387","author":"K Kayentao","year":"2022","unstructured":"Kayentao, K. et al. Safety and efficacy of a monoclonal antibody against malaria in Mali. N. Engl. J. Med. 387, 1833\u20131842 (2022).","journal-title":"N. Engl. J. Med."},{"key":"50770_CR65","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1056\/NEJMoa2034031","volume":"385","author":"MR Gaudinski","year":"2021","unstructured":"Gaudinski, M. R. et al. A monoclonal antibody for malaria prevention. N. Engl. J. Med. 385, 803\u2013814 (2021).","journal-title":"N. Engl. J. Med."},{"key":"50770_CR66","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1056\/NEJMoa2203067","volume":"387","author":"RL Wu","year":"2022","unstructured":"Wu, R. L. et al. Low-dose subcutaneous or intravenous monoclonal antibody to prevent malaria. N. Engl. J. Med. 387, 397\u2013407 (2022).","journal-title":"N. Engl. J. Med."},{"key":"50770_CR67","doi-asserted-by":"publisher","first-page":"1091961","DOI":"10.3389\/fimmu.2022.1091961","volume":"13","author":"P Chandley","year":"2023","unstructured":"Chandley, P., Ranjan, R., Kumar, S. & Rohatgi, S. Host-parasite interactions during Plasmodium infection: implications for immunotherapies. Front. Immunol. 13, 1091961 (2023).","journal-title":"Front. Immunol."},{"key":"50770_CR68","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/S0020-7519(97)00080-5","volume":"27","author":"W Trager","year":"1997","unstructured":"Trager, W. & Jensen, J. B. Continuous culture of Plasmodium falciparum: its impact on malaria research. Int. J. Parasitol. 27, 989\u20131006 (1997).","journal-title":"Int. J. Parasitol."},{"key":"50770_CR69","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1073\/pnas.1216457110","volume":"110","author":"RW Moon","year":"2013","unstructured":"Moon, R. W. et al. Adaptation of the genetically tractable malaria pathogen Plasmodium knowlesi to continuous culture in human erythrocytes. Proc. Natl Acad. Sci. USA 110, 531\u2013536 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"50770_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2021.100635","volume":"2","author":"DSM Chatzileontiadou","year":"2021","unstructured":"Chatzileontiadou, D. S. M., Szeto, C., Jayasinghe, D. & Gras, S. Protein purification and crystallization of HLA-A\u221702:01 in complex with SARS-CoV-2 peptides. STAR Protoc. 2, 100635 (2021).","journal-title":"STAR Protoc."},{"key":"50770_CR71","doi-asserted-by":"publisher","first-page":"4180","DOI":"10.1073\/pnas.83.12.4180","volume":"83","author":"A Minsky","year":"1986","unstructured":"Minsky, A., Summers, R. G. & Knowles, J. R. Secretion of beta-lactamase into the periplasm of Escherichia coli: evidence for a distinct release step associated with a conformational change. Proc. Natl Acad. Sci. USA 83, 4180\u20134184 (1986).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"50770_CR72","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1038\/nprot.2007.261","volume":"2","author":"J Rappsilber","year":"2007","unstructured":"Rappsilber, J., Mann, M. & Ishihama, Y. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat. Protoc. 2, 1896\u20131906 (2007).","journal-title":"Nat. Protoc."},{"key":"50770_CR73","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. XDS. Acta Crystallogr. D Biol. Crystallogr. 66, 125\u2013132 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"50770_CR74","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007).","journal-title":"J. Appl. Crystallogr."},{"key":"50770_CR75","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1107\/S0907444905001617","volume":"61","author":"AJ McCoy","year":"2005","unstructured":"McCoy, A. J., Grosse-Kunstleve, R. W., Storoni, L. C. & Read, R. J. Likelihood-enhanced fast translation functions. Acta Crystallogr. D Biol. Crystallogr. 61, 458\u2013464 (2005).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"50770_CR76","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"50770_CR77","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"50770_CR78","unstructured":"The PyMOL Molecular Graphics System (Schrodinger LLC, 2015)."},{"key":"50770_CR79","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1128\/JCM.44.5.1665-1673.2006","volume":"44","author":"KEM Persson","year":"2006","unstructured":"Persson, K. E. M., Lee, C. T., Marsh, K. & Beeson, J. G. Development and optimization of high-throughput methods to measure Plasmodium falciparum-specific growth inhibitory antibodies. J. Clin. Microbiol. 44, 1665\u20131673 (2006).","journal-title":"J. Clin. Microbiol."},{"key":"50770_CR80","doi-asserted-by":"crossref","unstructured":"Wickham, H. ggplot2: Elegant Graphics for Data Analysis (Springer, 2016).","DOI":"10.1007\/978-3-319-24277-4_9"},{"key":"50770_CR81","unstructured":"R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2023)."},{"key":"50770_CR82","doi-asserted-by":"publisher","first-page":"e0146021","DOI":"10.1371\/journal.pone.0146021","volume":"10","author":"C Ritz","year":"2016","unstructured":"Ritz, C., Baty, F., Streibig, J. C. & Gerhard, D. Dose-response analysis using R. PLoS ONE 10, e0146021 (2016).","journal-title":"PLoS ONE"},{"key":"50770_CR83","doi-asserted-by":"publisher","first-page":"708","DOI":"10.4269\/ajtmh.2006.74.708","volume":"74","author":"J Sattabongkot","year":"2006","unstructured":"Sattabongkot, J. et al. Establishment of a human hepatocyte line that supports in vitro development of the exo-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax. Am. J. Trop. Med. Hyg. 74, 708\u2013715 (2006).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"50770_CR84","doi-asserted-by":"publisher","first-page":"3796","DOI":"10.1016\/j.celrep.2019.11.073","volume":"29","author":"C Jennison","year":"2019","unstructured":"Jennison, C. et al. Inhibition of plasmepsin V activity blocks Plasmodium falciparum gametocytogenesis and transmission to mosquitoes. Cell Rep. 29, 3796\u20133806.e3794 (2019).","journal-title":"Cell Rep."},{"key":"50770_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32076-8","volume":"13","author":"S Lopaticki","year":"2022","unstructured":"Lopaticki, S. et al. Tryptophan C-mannosylation is critical for Plasmodium falciparum transmission. Nat. Commun. 13, 4400 (2022).","journal-title":"Nat. Commun."},{"key":"50770_CR86","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1080\/15548627.2015.1067361","volume":"11","author":"M Prado","year":"2015","unstructured":"Prado, M. et al. Long-term live imaging reveals cytosolic immune responses of host hepatocytes against Plasmodium infection and parasite escape mechanisms. Autophagy 11, 1561\u20131579 (2015).","journal-title":"Autophagy"},{"key":"50770_CR87","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.chom.2020.02.005","volume":"27","author":"P Favuzza","year":"2020","unstructured":"Favuzza, P. et al. Dual plasmepsin-targeting antimalarial agents disrupt multiple stages of the malaria parasite life cycle. Cell Host Microbe 27, 642\u2013658.e612 (2020).","journal-title":"Cell Host Microbe"},{"key":"50770_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2023.115730","volume":"236","author":"C Marin","year":"2023","unstructured":"Marin, C. et al. Determination of plasma concentration of Belimumab by LC-MS\/MS: method development, validation, and clinical application. J. Pharm. Biomed. Anal. 236, 115730 (2023).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"50770_CR89","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41596-018-0082-x","volume":"14","author":"CS Hughes","year":"2019","unstructured":"Hughes, C. S. et al. Single-pot, solid-phase-enhanced sample preparation for proteomics experiments. Nat. Protoc. 14, 68\u201385 (2019).","journal-title":"Nat. Protoc."},{"key":"50770_CR90","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/mas.21540","volume":"39","author":"LK Pino","year":"2020","unstructured":"Pino, L. K. et al. The Skyline ecosystem: informatics for quantitative mass spectrometry proteomics. Mass Spectrom. Rev. 39, 229\u2013244 (2020).","journal-title":"Mass Spectrom. Rev."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50770-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50770-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50770-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T06:48:25Z","timestamp":1724395705000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50770-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,22]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["50770"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-50770-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3671797\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,22]]},"assertion":[{"value":"12 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was a collaboration between AdAlta Limited and La Trobe University. M.F. is the founding chief scientist and a shareholder in AdAlta Ltd., and R.F.A. is also a shareholder in AdAlta. The other authors have declared no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7206"}}